Mesk A. Alrais
University of Texas Health Science Center at Houston
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mesk A. Alrais.
Future Science OA | 2016
Hind N. Moussa; Mesk A. Alrais; Mateo Leon; Elizabeth L Abbas; Baha M. Sibai
The obesity epidemic is on the rise throughout the USA and the world. Not only does it affect the general population but it also specifically poses unique threats to a woman’s life in the antepartum, peripartum and postpartum periods. An increased BMI is associated with worse perinatal outcomes, including higher rates of preeclampsia (and other hypertensive disorders), macrosomia, other neonatal morbidities and gestational diabetes. Isolated maternal obesity and additional maternal diabetes predispose the infant to potential adult disease through fetal programming. This review of the literature examines the effects of obesity on a woman’s life, outlining complications beginning with preconception through the postpartum period.
Obstetrics & Gynecology | 2017
Oscar A. Viteri; Joey A. England; Mesk A. Alrais; Kayla A. Lash; Maria I. Villegas; Olaide A. Ashimi Balogun; Suneet P. Chauhan; Baha M. Sibai
OBJECTIVE To estimate whether nonsteroidal antiinflammatory drugs (NSAIDs) are associated with persistent postpartum hypertension in a cohort of women with preeclampsia and severe features. METHODS We conducted a retrospective cohort study at a single, tertiary center from January 2013 to December 2015. All women diagnosed with severe preeclampsia who remained hypertensive for greater than 24 hours after delivery were included. The primary outcome was the rate of persistent postpartum hypertension, defined as systolic blood pressure 150 mm Hg or greater or diastolic 100 mm Hg or greater (or both), on two occasions, at least 4 hours apart. Secondary outcomes included severe maternal morbidity: pulmonary edema, renal dysfunction, stroke, eclampsia, and intensive care unit admission. Additional outcomes included length of postpartum hospital stay, receipt of narcotics, and hospital readmission. Multivariable logistic regression was performed to adjust for confounders. Adjusted odds ratios (ORs) are reported for applicable study outcomes. RESULTS Of the 399 women with severe preeclampsia, 324 (81%) remained hypertensive 24 hours after delivery. Two hundred forty-three (75%) received NSAIDs (either ibuprofen or ketorolac) and 81 (25%) did not. After multivariable logistic regression, the likelihood of reaching a blood pressure of 150 mm Hg systolic or 100 mm Hg diastolic (or both), on two occasions, at least 4 hours apart, was similar between those who received NSAIDs compared with those who did not (70% compared with 73%; adjusted OR 1.1, 95% CI 0.6-2.0). Similarly, puerperal occurrence of pulmonary edema (3% compared with 10%; OR 4.4, 95% CI 1.5-13.1), renal dysfunction (5% compared with 8%; OR 1.7, 95% CI 0.6-4.8), eclampsia (1% compared with 0%; P=.34), or intensive care unit admission (3% compared with 8%; OR 2.4, 95% CI 0.8-7.1) was similar between the groups. There were no differences in the rate of narcotic use (89% compared with 75%; adjusted OR 0.6 95% CI 0.18-1.70). CONCLUSION In this cohort of women with preeclampsia and severe features before delivery, NSAIDs were not associated with increased rates of persistent postpartum hypertension.
American Journal of Perinatology | 2018
Nana Ama E. Ankumah; Sean C. Blackwell; Mesk A. Alrais; Farah H. Amro; Rachel Wiley; Patricia A. Heale; Maria Hutchinson; Baha M. Sibai
Background Although supplemental oxygen (SO2) is routinely administered to laboring gravidas, benefits and harms are not well studied. Objective This article compares strategies of liberal versus indicated SO2therapy during labor on cesarean delivery (CD) rate and neonatal outcomes. Study Design A controlled, before‐and‐after trial of laboring women with term, singleton pregnancies. During an initial 8‐week period, maternal SO2was administered at the discretion of the provider followed by an 8‐week period where SO2was to be given only for protocol indications. Results Our study included 844 women. There was no difference in number of women receiving SO2(53% liberal vs. 50% indicated; p = 0.33). For those receiving SO2, there was no difference in SO2duration (median, 89 minutes [interquartile range, 42‐172] vs. 87 minutes [36‐152]; p = 0.42). There were no differences in overall CD rate (20% vs. 17%; p = 0.70), CD for nonreassuring fetal status, or use of intrauterine resuscitative measures. There were more 5‐minute APGAR < 7 in the indicated group, but no difference in umbilical artery pH < 7.1 or neonatal intensive care unit (NICU) admission. Conclusion Approximately half of women receive SO2intrapartum regardless of a strategy of liberal or indicated oxygen use. There were no clinically significant differences in outcomes between strategies.
American Journal of Obstetrics and Gynecology | 2018
Daniela Menichini; Mesk A. Alrais; Esther Tamayo; Chen Liu; Sean C. Blackwell; Fabio Facchinetti; Baha M. Sibai; Monica Longo
American Journal of Obstetrics and Gynecology | 2017
Monica Longo; Mesk A. Alrais; Esther Tamayo; Alejandra E. Ontiveros; Francesca Ferrari; Fabio Facchinetti; Jerrie Refuerzo; Sean C. Blackwell; Baha M. Sibai
Obstetrics & Gynecology | 2018
Oscar A. Viteri; Mesk A. Alrais; Claudia Pedroza; Maria Hutchinson; Suneet P. Chauhan; Sean C. Blackwell; Baha M. Sibai
Obstetrics & Gynecology | 2018
Susan Hosseini Nasab; Hind N. Moussa; Mesk A. Alrais; Baha M. Sibai; Sean C. Blackwell
Obstetrics & Gynecology | 2018
Mesk A. Alrais; Han-Yang Chen; Baha M. Sibai; Sean C. Blackwell
American Journal of Obstetrics and Gynecology | 2018
Mesk A. Alrais; Oscar A. Viteri; Baha M. Sibai; Chauhan Suneet; Gyamfi-Bannerman Cynthia; Joaquin A. Villegas; Han-Yang Chen; Sean C. Blackwell
American Journal of Obstetrics and Gynecology | 2018
Daniela Menichini; Mesk A. Alrais; Esther Tamayo; Chen Liu; Sean C. Blackwell; Fabio Facchinetti; Baha M. Sibai; Monica Longo